Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

著者: Yung‐Jue Bang, Rui‐Hua Xu, Keisho Chìn, Keun‐Wook Lee, Se Hoon Park, Sun Young Rha, Lin Shen, Shukui Qin, Nong Xu, Seock‐Ah Im, Gershon Y. Locker, Philip Rowe, Xiaojin Shi, Darren Hodgson, Yu-Zhen Liu, Narikazu Boku - The Lancet 2017 被引用: 291